Press Releases from 121Doc (1 total)
Miracle anti-obesity pill Acomplia rimonabant launched in Europe
Acomplia, the brand name of Rimonabant has been developed by the French Pharmaceutical giant Sanofi-Aventis to act as a major deterrent to increasing obesity and smoking. Although it has been permitted to be marketed only as a anti-obesity drug it possesses wondrous properties of curbing smoking and persuade heavy smokers to relinquish the habit as per clinical test results. This drug Acomplia Rimonabant acts on the complex mechanism of the…
